| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Tony J Prescott, Fernando M Montes González, Kevin Gurney, Mark D Humphries, Peter Redgrav. Simulated Dopamine Modulation of a Neurorobotic Model of the Basal Ganglia. Biomimetics (Basel, Switzerland). vol 9. issue 3. 2024-03-27. PMID:38534824. |
the effective operation of basal ganglia circuitry is also known to rely on appropriate levels of the neurotransmitter dopamine. |
2024-03-27 |
2024-03-29 |
Not clear |
| Oliver D Howes, Bernard R Bukala, Katherine Bec. Schizophrenia: from neurochemistry to circuits, symptoms and treatments. Nature reviews. Neurology. 2023-12-19. PMID:38110704. |
this evidence demonstrates regionally specific neurotransmitter alterations, including higher glutamate and dopamine measures in the basal ganglia, and lower glutamate, dopamine and γ-aminobutyric acid (gaba) levels in cortical regions, particularly the frontal cortex, relative to healthy individuals. |
2023-12-19 |
2023-12-21 |
Not clear |
| Sarah Remahi, Madora Mabika, Samantha Côté, Christian Iorio-Morin, Jamie Near, Steve C N Hui, Richard A E Edden, Hugo Théoret, Kevin Whittingstall, Jean-François Lepag. Neurotransmitter levels in the basal ganglia are associated with intracortical circuit activity of the primary motor cortex in healthy humans. Progress in neuro-psychopharmacology & biological psychiatry. 2023-11-12. PMID:37952692. |
neurotransmitter levels in the basal ganglia are associated with intracortical circuit activity of the primary motor cortex in healthy humans. |
2023-11-12 |
2023-11-20 |
Not clear |
| Sarah Remahi, Madora Mabika, Samantha Côté, Christian Iorio-Morin, Jamie Near, Steve C N Hui, Richard A E Edden, Hugo Théoret, Kevin Whittingstall, Jean-François Lepag. Neurotransmitter levels in the basal ganglia are associated with intracortical circuit activity of the primary motor cortex in healthy humans. Progress in neuro-psychopharmacology & biological psychiatry. 2023-11-12. PMID:37952692. |
interestingly, several disorders showing abnormal neurotransmitter levels in basal ganglia also present concomitant anomalies in intracortical function within m1. |
2023-11-12 |
2023-11-20 |
Not clear |
| Anna D Shitova, Tatyana S Zharikova, Olga N Kovaleva, Anastasia M Luchina, Arthur S Aktemirov, Anna V Olsufieva, Mikhail Y Sinelnikov, André Pontes-Silva, Yury O Zhariko. Tourette Syndrome and Obsessive-Compulsive Disorder: A Comprehensive Review of Structural Alterations and Neurological Mechanisms. Behavioural brain research. 2023-07-31. PMID:37524204. |
the main cstcs involved in the pathological process have been identified by studying structural and neurotransmitter disturbances in the interaction between the cortex and the basal ganglia. |
2023-07-31 |
2023-08-14 |
Not clear |
| Maria Mancini, Silvia Natoli, Fabrizio Gardoni, Monica Di Luca, Antonio Pisan. Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19. International journal of molecular sciences. vol 24. issue 6. 2023-03-29. PMID:36982693. |
dopamine (da) is a key neurotransmitter in the basal ganglia, implicated in the control of movement and motivation. |
2023-03-29 |
2023-08-14 |
Not clear |
| Xiao-Bei Sun, Zhong-Ren Sun, Hong-Na Yin, Shao-Peng Li. [Progress of researches on mechanisms of acupuncture in treatment of Parkinson's disease]. Zhen ci yan jiu = Acupuncture research. vol 46. issue 11. 2021-12-08. PMID:34865337. |
by analyzing the experimental researches on acupuncture therapy of pd over the past 10 years, the authors find that acupuncture can play a therapeutic role by regulating multiple targets such as basal ganglia neurotransmitter disorder, oxidative stress, abnormal protein folding, immune inflammatory response, apoptosis, neural stem cells and calcium homeostasis. |
2021-12-08 |
2023-08-13 |
Not clear |
| Ariana Z Turk, Mahsa Lotfi Marchoubeh, Ingrid Fritsch, Gerald A Maguire, Shahriar SheikhBahae. Dopamine, vocalization, and astrocytes. Brain and language. vol 219. 2021-10-25. PMID:34098250. |
dopamine, the main catecholamine neurotransmitter in the brain, is predominately produced in the basal ganglia and released to various brain regions including the frontal cortex, midbrain and brainstem. |
2021-10-25 |
2023-08-13 |
Not clear |
| Atul Goel, Ramkumar Sugumaran, Sunil K Naraya. Zonisamide in Parkinson's disease: a current update. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. vol 42. issue 10. 2021-09-17. PMID:34448999. |
parkinson's disease (pd) is a progressive neurodegenerative disease due to the depletion of the neurotransmitter dopamine in basal ganglia. |
2021-09-17 |
2023-08-13 |
Not clear |
| Maria A Briscione, Ashok R Dinasarapu, Pritha Bagchi, Yuping Donsante, Kaitlyn M Roman, Anthony M Downs, Xueliang Fan, Jessica Hoehner, H A Jinnah, Ellen J Hes. Differential expression of striatal proteins in a mouse model of DOPA-responsive dystonia reveals shared mechanisms among dystonic disorders. Molecular genetics and metabolism. vol 133. issue 4. 2021-09-16. PMID:34092491. |
the inherited metabolic disorder dopa-responsive dystonia is considered a prototype for understanding basal ganglia dysfunction in dystonia because it is caused by mutations in genes necessary for the synthesis of the neurotransmitter dopamine, which mediates the activity of the basal ganglia. |
2021-09-16 |
2023-08-13 |
mouse |
| Yadan Zhao, Zichen Zhang, Siru Qin, Wen Fan, Wei Li, Jingyi Liu, Songtao Wang, Zhifang Xu, Meidan Zha. Acupuncture for Parkinson's Disease: Efficacy Evaluation and Mechanisms in the Dopaminergic Neural Circuit. Neural plasticity. vol 2021. 2021-07-29. PMID:34221005. |
it has also been found that acupuncture can protect dopaminergic neurons from degeneration via antioxidative stress, anti-inflammatory, and antiapoptotic pathways as well as modulating the neurotransmitter balance in the basal ganglia circuit. |
2021-07-29 |
2023-08-13 |
Not clear |
| Stanley N Caroff, Rakesh Jain, James F Morle. Revisiting amantadine as a treatment for drug-induced movement disorders. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 32. issue 3. 2021-06-21. PMID:32722730. |
amantadine, an aliphatic primary amine with complex actions on neurotransmitter systems in the basal ganglia, is approved for treating parkinson's disease and drug-induced movement disorders (dimds). |
2021-06-21 |
2023-08-13 |
Not clear |
| Rafael Gonzalo-Gobernado, Diana Reimers, María José Casarejos, Lucía Calatrava Ferreras, Manuela Vallejo-Muñoz, Adriano Jiménez-Escrig, Juan José Diaz-Gil, Gonzalo M Ulzurrun de Asanza, Eulalia Bazá. Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´s Disease. Brain sciences. vol 10. issue 5. 2020-09-28. PMID:32455921. |
parkinson's disease is a neurodegenerative disorder characterized by the progressive death of dopaminergic (da) neurons in the substantia nigra (sn), which leads to a loss of the neurotransmitter dopamine in the basal ganglia. |
2020-09-28 |
2023-08-13 |
rat |
| Ana Muñoz, Andrea Lopez-Lopez, Carmen M Labandeira, Jose L Labandeira-Garci. Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson's Disease and Adverse Effects of L-DOPA. Frontiers in neuroanatomy. vol 14. 2020-09-28. PMID:32581728. |
interactions between the serotonergic and other neurotransmitter systems in the basal ganglia: role in parkinson's disease and adverse effects of l-dopa. |
2020-09-28 |
2023-08-13 |
Not clear |
| Christopher W Tschumi, Michael J Beckstea. Diverse actions of the modulatory peptide neurotensin on central synaptic transmission. The European journal of neuroscience. vol 49. issue 6. 2020-07-22. PMID:29405480. |
in the basal ganglia as well as other brain nuclei, nt can act through diverse intracellular signaling cascades to enhance or depress neuronal activity by modulating activity of ion channels, ionotropic and metabotropic neurotransmitter receptors, and presynaptic release of neurotransmitters. |
2020-07-22 |
2023-08-13 |
Not clear |
| Eliseu da Cruz Moreira-Junio. Hyper-serotonergic state determines onset and progression of idiopathic Parkinson's disease. Medical hypotheses. vol 133. 2020-07-07. PMID:31542611. |
the strong serotonergic connection between the raphe nuclei and the dorsal raphe nuclei with the basal ganglia, all important brain structures associated with the pathophysiology of pd, emphasize a potential role for this neurotransmitter in pd. |
2020-07-07 |
2023-08-13 |
Not clear |
| David A Kupferschmidt, Shana M Augustin, Kari A Johnson, David M Lovinge. Active Zone Proteins RIM1αβ Are Required for Normal Corticostriatal Transmission and Action Control. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 39. issue 8. 2019-12-30. PMID:30559150. |
together, these findings reveal a selective role for presynaptic rim1 in neurotransmitter release at prominent basal ganglia synapses, and provide evidence that rim1-dependent processes help to promote the refinement of skilled actions, constrain goal-directed behaviors, and support the learning and use of habits. |
2019-12-30 |
2023-08-13 |
mouse |
| Arun Sing. Oscillatory activity in the cortico-basal ganglia-thalamic neural circuits in Parkinson's disease. The European journal of neuroscience. vol 48. issue 8. 2019-11-14. PMID:29381817. |
dopamine is an important neurotransmitter that maintains the balance within the basal ganglia between the direct pathway, which promotes movement, and the indirect pathway, which inhibits movement. |
2019-11-14 |
2023-08-13 |
Not clear |
| Timothy C Whalen, Aryn H Gitti. Histamine and deep brain stimulation: the pharmacology of regularizing a brain. The Journal of clinical investigation. vol 128. issue 12. 2019-09-05. PMID:30371507. |
parkinson's disease (pd) patients have increased histamine in their basal ganglia, but the role of this neurotransmitter in pd is poorly understood. |
2019-09-05 |
2023-08-13 |
Not clear |
| Lyudmila Pivina, Yuliya Semenova, Monica Daniela Doşa, Marzhan Dauletyarova, Geir Bjørklun. Iron Deficiency, Cognitive Functions, and Neurobehavioral Disorders in Children. Journal of molecular neuroscience : MN. vol 68. issue 1. 2019-05-29. PMID:30778834. |
iron deficiency can cause changes in neurotransmitter homeostasis, decrease myelin production, impair synaptogenesis, and decline the function of the basal ganglia. |
2019-05-29 |
2023-08-13 |
Not clear |